First-in-human Study to Assess the Safety and Pharmacokinetics of LML134 in Healthy Volunteers

NCT02334449 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: LML134
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals